GALT Competitors & Alternatives
Compare Galectin Therapeutics Inc with similar stocks in the same industry
Biotechnology
GALT
Main Stock$3.41
Tradestie Score
62
Market Cap
$267.77M
Analyst Upside
+222.8%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$10.69
|
$386.68M | - | 54 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$7.33
|
$382.04M | - | 44 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$14.27
|
$371.64M | - | 59 | Compare |
|
CAPR
Capricor Therapeutics Inc
|
$10.27
|
$357.51M | - | 36 | Compare |
|
DMAC
DiaMedica Therapeutics Inc. Common Stock
|
$9.63
|
$354.59M | - | 39 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$11.30
|
$354.45M | - | 57 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$44.98
|
$353.70M | - | 37 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$4.19
|
$332.96M | - | 36 | Compare |
|
REPL
Replimune Group, Inc.
|
$22.60
|
$328.62M | - | 33 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$9.39
|
$304.12M | - | 45 | Compare |
More GALT Analysis
Data updated: Nov 11, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry